Seikagaku Corp. manufactures pharmaceuticals and medical devices with glycoconjugates; specifically, glycosaminoglycans (GAG) such as hyaluronic acid; as well as enzymes that act on GAG. It operates through the following segments: Pharmaceuticals and Limulus Amebocyte Lysate (LAL). The Pharmaceuticals segment develops and supplies intra-articular injections for improving joint functions, cross-linked hyaluronate hydrogel for knee osteoarthritis, opthalmic surgical aids, and surgical aids for endoscopic mucosal resection. The LAL segment manufactures and sells endotoxin-detecting reagents in Japan and overseas. The company was founded on June 2, 1947 and is headquartered in Tokyo, Japan.

Sanofi Genzyme is the specialty care global business unit of Sanofi, focused on rare diseases, multiple sclerosis, immunology, and oncology. They help people with debilitating and complex conditions that are often difficult to diagnose and treat. They are dedicated to discovering and advancing new therapies, providing hope to patients and their families around the world. Genzyme became part of Sanofi in 2011. While continuing to focus on rare diseases, they also established ourselves as a leader in the field of multiple sclerosis. In 2016, their focus expanded to include Sanofi’s programs in oncology and immunology. Their approach is shaped by a long history of developing highly specialized treatments and forging close relationships with physician and patient communities. Founded as Genzyme in Boston in 1981, they rapidly grew to become one of the world’s leading biotechnology companies, recognized for their pioneering development of treatments for rare genetic disorders and their innovative contributions to medical science and biomanufacturing.

Fidia Farmaceutici SpA manufactures pharmaceutical products. The firm's platform technology level is the chemical modification, development, and manufacturing of state-of-the-art pharmaceuticals and medical devices based on hyaluronan covering therapeutic categories. The company was founded in 1946 and is headquartered in Abano Terme, Italy.

Istituto Luso Farmaco d'Italia SpA manufactures pharmaceutical products. It offers aloneb, auradol, bifril, kimono, exorta, altiazem, gutron, overal, nobistar, miolene and formistin. The company was founded in 1951 and is headquartered in Rozzano, Italy.

Carticept Medical, Inc. develops and markets medical devices. It develops platform technologies to improve the safety, efficiency, and accuracy of many common injection procedures. The firm's Navigator Delivery System, a FDA-cleared computer controlled medication delivery system for intra-articular injections. The company was founded by Timothy J. Patrick and Peter J. Pizzo, III in 2005 and is headquartered in Alpharetta, GA.

ALZA Corp. is a pharmaceutical and medical systems company that develops, manufactures, and markets therapeutic systems. It provides oral, transdermal, implantable, and liposomal technologies. It is also focused on drug delivery systems with over 20 prescription pharmaceutical products. With over 10,000 employees, ALZA Corp. is a subsidiary of Johnson & Johnson. It was established in 1968 by Dr Alejandro Zaffaroni. It is based inVacaville, California.

Allergan, Inc. operated as a global healthcare company. It engaged in the development and commercialization of specialty pharmaceutical, medical device ,and over-the-counter products for the ophthalmic, neurological, medical aesthetics, medical dermatology, breast aesthetics, obesity intervention, urological, and other specialty markets. The company was founded by Gavin S. Herbert in 1950 and headquartered in Irvine, CA.

Semnur Pharmaceuticals, Inc. develops and manufactures pharmaceutical products. The firm focuses on the clinical and commercial development of products such as SP-102: a non-opioid epidural steroid injectable potentially for the treatment of Lumbosacral radicular pain. The company was founded by Mahendra G. Shah in 2013 and is headquartered in Mountain View, CA.

They want to take the world from pain to pain-free parenterals through dedicated work on creating innovations. Emal the first in the world injectable medicine against critical malaria, Etojet – the world’s first painless Etrocoxib injection and a first of it’s kind injectable Diclofenac Sodium for pain relief, are all a result of the pursuit of ideas taken to their full potential. Their aim is to make disease management easier and painless for both patients and healthcare professionals.

Bone Therapeutics is a international biopharmaceutical company focused on innovative cell therapy products for the treatment of bone diseases. Utilizing the Company's unique knowledge of the bone/joint physiology and long-standing expertise in cell therapy and cell transplantation, Bone Therapeutics has created a fully integrated business with an advanced product pipeline comprising novel bone cell products, tailored in-house production methods, and minimally invasive treatment techniques.

Cartificial A/S develops and markets implants based on composite polymer technology. Its main products, Cartificial Hip can be inserted during day care surgery. The company was founded in 2000 and is headquartered in Vedbaek, Denmark.

DePuy Synthes Products, Inc. develops and markets medical products. It offers distal volar Radius, which is designed to treat distal radius fractures, dorsal endoplate, an invasive dorsal nail plate that provides fixed angle support and intramedullary locked fixation with a duplicate and reproducible surgical procedure, spatial subchondral support plate, which is used to treat proximal humeral fractures and Small Bone Fixation System, a percutaneous locked intramedullary nail system for metacarpals and the phalanges. The company was founded on June 22, 2004 and is headquartered in Wilmington, DE.

Aptissen S.A. was founded in 2013 as a spin-off of ANTEIS, and is based in Geneva area, Switzerland. The company is specialized in the development, distribution, and commercialization of biopolymer-based medical devices (Synolis VA range) and food supplement (Cartylis) in the area of joint health. Aptissen’s team revolutionized the viscosupplement market with Synolis VA and its patented formulation which combines Hyaluronic Acid and Sorbitol. Synolis VA provides rapid mobility recovery, fast long-lasting pain relief associated with excellent safety. Aptissen distributes its products through a worldwide international distributors' network among more than 50 countries including Europe, South America, Canada, Middle East and Asia. It has subsidiaries in Italy, Poland & France and two license partners. Aptissen is 100% subcontracted and has 3 supply sources located in Europe, with a marging rate of 67%. The company has the following certifications: CE certified, ISO13485, MDSAP & GMP compliant, MDR ready.

Security Expert Guard Agency of Liberia (doing business as SEGAL) is a private company headquartered in Monrovia, Liberia, that provides security services.

KitoZyme designs, manufactures and markets medical devices, food supplements and oenological ingredients from non-animal chitosan and chitin-glucan. KitoZyme is focused on providing solutions and outstanding services to our customers. KitoZyme is renowned for continually delivering new products and closely assisting our clients at every moment. Forever innovating, we are the long term partner that successfully produces complete solutions and helps create the future portfolios of clients all over the world. These solutions mainly come in the form of medical devices that are based on unique and patented technologies, namely chitosan and chitin-glucan manufactured from non-animal and non-GMO sources. Both the performance and safety of all of these technologies are scientifically and clinically proven.

Pfizer Inc. (NYSE: PFE, /ˈfaɪzər/) is an American multinational pharmaceutical corporation headquartered in New York City was founded in 1849, based in New York City and was listed on New York Stock Exchange. It is one of the world's largest pharmaceutical companies. It is listed on the New York Stock Exchange, and its shares have been a component of the Dow Jones Industrial Average since 2004. Pfizer ranked No. 57 on the 2018 Fortune 500 list of the largest United States corporations by total revenue.

TRB Chemedica AG, a subsidiary of TRB Chemedica International SA, is a German company located in Munich that manufactures pharmaceutical solutions with hyaluronic acid. The firm was founded in 1996.